Pharmacist's geriatric assessment can provide valuable insights into potential deprescribing targets, while including important information on various health-related domains. Data collected from a geriatric assessment questionnaire, for 388 patients, from the Croatian cohort of the EuroAgeism H2020 ESR 7 international project, along with guideline-based deprescribing criteria, were used to analyse potentially inappropriate prescribing of four medication groups (benzodiazepines (BZN), proton pump inhibitors (PPI), opioids, and non-steroidal anti-inflammatory drugs (NSAID)), and to assess the deprescribing potential. Binary logistic regression was used to explore the effects of age, gender, number of medicines and diagnoses, self-reported health, frailty score, and healthcare utilization on the likelihood of needing deprescribing. More than half of participants (n = 216, 55.2%) are candidates for deprescribing, with 31.1% of PPI, 74.8% of NSAID, 75% of opioid, and 96.1% of BZN users meeting at least one criterion. Most common criteria for deprescribing were inappropriately long use and safety concerns. Women (aOR = 2.58; p < 0.001), those reporting poor self-reported health (aOR = 5.14; p < 0.001), and those exposed to polypharmacy (aOR = 1.29; p < 0.001) had higher odds of needing to have medicines deprescribed. The high rate of deprescribing potential warrants prompt action to increase patient safety and decrease polypharmacy. Pharmacist's geriatric assessment and deprescribing-focused medication review could be used to lead a personalised approach.

City Pharmacies Zagreb Kralja Držislava 6 Zagreb Croatia

Department of Geriatrics and Gerontology 1st Faculty of Medicine Prague Charles University Kateřinská 32 Prague Czech Republic

Department of Social and Clinical Pharmacy Faculty of Pharmacy in Hradec Králové Charles University Akademika Heyrovského 1203 8 Hradec Králové Prague Czech Republic

Department of Social Pharmacy and Pharmaceutical Legislation Faculty of Pharmacy University of Belgrade 450 Vojvode Stepe Street Belgrade Serbia

Faculty of Pharmacy and Biochemistry Center for Applied Pharmacy University of Zagreb Ante Kovačića 1 10 000 Zagreb Croatia

Erratum v

Sci Rep. 2024 Apr 22;14(1):9236. doi: 10.1038/s41598-024-60073-y. PubMed

Zobrazit více v PubMed

World Health Organization. Decade of Healthy Ageing: Baseline Report. World Health Organization (2020).

Roux B, Sirois C, Simard M, Gagnon ME, Laroche ML. Potentially inappropriate medications in older adults: A population-based cohort study. Fam. Pract. 2020;37:173–179. PubMed

Malakouti SK, et al. A systematic review of potentially inappropriate medications use and related costs among the elderly. Value Heal. Reg. Issues. 2021;25:172–179. doi: 10.1016/j.vhri.2021.05.003. PubMed DOI

Barry HE, Hughes CM. An update on medication use in older adults: A narrative review. Curr. Epidemiol. Rep. 2021;8:108. doi: 10.1007/s40471-021-00274-5. PubMed DOI PMC

Linsky A, Gellad WF, Linder JA, Friedberg MW. Advancing the science of deprescribing: A novel comprehensive conceptual framework. J. Am. Geriatr. Soc. 2019;67:2018–2022. doi: 10.1111/jgs.16136. PubMed DOI PMC

Gnjidic D, Reeve E. Deprescribing: What do we know, and where to next? Br. J. Clin. Pharmacol. 2021;87:722–724. doi: 10.1111/bcp.14525. PubMed DOI

Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br. J. Clin. Pharmacol. 2014;78:738–747. doi: 10.1111/bcp.12386. PubMed DOI PMC

Dharmarajan TS. Comprehensive geriatric assessment. Geriatr. Gastroenterol. 2021 doi: 10.1007/978-3-030-30192-7_8. DOI

Mangin D, et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position statement and 10 recommendations for action. Drugs Aging. 2018;35:575. doi: 10.1007/s40266-018-0554-2. PubMed DOI PMC

Ward, K. T. & Reuben, D. B. Comprehensive geriatric assessment—UpToDate. https://www.uptodate.com/contents/comprehensive-geriatric-assessment (2022).

Godbole G, Bolitho R, Pont L. Key concepts in medication management in older persons for pharmacists practicing in non-geriatric specialties. J. Pharm. Pract. Res. 2021;51:427–434. doi: 10.1002/jppr.1765. DOI

Delgado-Silveira E, Bermejo-Vicedo T. The role of pharmacists in geriatric teams: The time is now. Eur. Geriatr. Med. 2021;12:1119–1121. doi: 10.1007/s41999-021-00501-8. PubMed DOI

EuroAgeism—Inappropriate Prescribing and Availability of Medication Management Services in Older Patients in Europe. https://euroageism.eu/projects/inappropriate-prescribing-and-availability-of-medication-management-services-in-older-patients-in-europe/.

DiMnrin-Ghnlili RA. Integrating nutrition in the comprehensive geriatric assessment. Nutr. Clin. Pract. 2014;29:420–427. doi: 10.1177/0884533614537076. PubMed DOI

Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J. Cachexia. Sarcopenia Muscle. 2016;7:28. doi: 10.1002/jcsm.12048. PubMed DOI PMC

Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J. Gerontol. Ser. A. 1999;54:M546–M553. doi: 10.1093/gerona/54.11.M546. PubMed DOI

Church S, Rogers E, Rockwood K, Theou O. A scoping review of the clinical frailty scale. BMC Geriatr. 2020;20:1–18. doi: 10.1186/s12877-020-01801-7. PubMed DOI PMC

Morris JN, et al. MDS cognitive performance Scale©. J. Gerontol. 1994;49:M174–M182. doi: 10.1093/geronj/49.4.M174. PubMed DOI

Burrows AB, Morris JN, Simon SE, Hirdes JP, Phillips C. Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing. 2000;29:165–172. doi: 10.1093/ageing/29.2.165. PubMed DOI

Melzack R. The short-form McGill pain questionnaire. Pain. 1987;30:191–197. doi: 10.1016/0304-3959(87)91074-8. PubMed DOI

Croatian Bureau of Statistics. Population statistics. https://podaci.dzs.hr/en/statistics/population/ (2022).

Primary Health Tasmania, A. Resources: Medication management—deprescribing. https://www.primaryhealthtas.com.au/resources/deprescribing-resources/ (2022).

American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. (2023) 10.1111/JGS.18372.

Mann N-K, et al. Potentially inadequate medications in the elderly: PRISCUS 2.0 first update of the PRISCUS list. Dtsch Arztebl Int. 2023;120:3. PubMed PMC

Rodríguez-Pérez A, et al. Novel tool for deprescribing in chronic patients with multimorbidity: List of evidence-based deprescribing for chronic patients criteria. Geriatr. Gerontol. Int. 2017;17:2200–2207. doi: 10.1111/ggi.13062. PubMed DOI

O’Mahony D, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 3. Eur. Geriatr. Med. 2023;2023(1):1–8. PubMed PMC

Lavan AH, et al. STOPPFrail (screening tool of older persons prescriptions in frail adults with limited life expectancy): Consensus validation. Age Ageing. 2017;46:600–607. PubMed

Seppala LJ, et al. STOPPFall (screening tool of older persons prescriptions in older adults with high fall risk): A Delphi study by the EuGMS task and finish group on fall-risk-increasing drugs. Age Ageing. 2021;50:1189–1199. doi: 10.1093/ageing/afaa249. PubMed DOI PMC

Primary Health Tasmania, A. A Guide to Benzodiazepines Recommended Deprescribing Strategy. (2019).

Primary Health Tasmania, A. Opioids Recommended Deprescribing Strategy. (2019).

Primary Health Tasmania, A. Non-Steroidal Anti-Inflamatory Drugs Recommended Deprescribing Strategy (NSAIDs). (2019).

NSW Therapeutic Advisory Group, A. Deprescribing Guide for Benzodiazepines and Z-Drugs. (2018).

NSW Therepautic Advisory Group, A. Deprescribing Guide for Regular Long-Term Opioid Analgesic Use in Older Adults. (2018).

Farrell B, et al. Clinical practice guidelines deprescribing proton pump inhibitors evidence-based clinical practice guideline. Can. Fam. Physician Le Médecin Fam. Can. 2017;63:354–364. PubMed PMC

American Geriatrics Society. AGS Clinical Practice Guidelines and Recommendations. https://geriatricscareonline.org/ProductTypeStore/guidelines-recommendations-position-statements-/8/.

British Geriatrics Society. Clinical guidelines. https://www.bgs.org.uk/resources/resource-series/clinical-guidelines.

Agency for Medicinal Products and Medical Devices of Croatia, H. Medicinal products database for dug group N05B and N05C (benzodiazepine receptor agonists). Medicinal Products Databasehttps://www.halmed.hr/Lijekovi/Baza-lijekova/#rezultati.

Wolters Kluwer. Lexicomp Drug Interactions Module. https://www.wolterskluwer.com/en/solutions/lexicomp/lexicomp.

Shetty, V. et al. Evaluation of potential drug-drug interactions with medications prescribed to geriatric patients in a Tertiary Care Hospital. J. Aging Res.2018, (2018). PubMed PMC

Cheong ST, Ng TM, Tan KT. Pharmacist-initiated deprescribing in hospitalised elderly: Prevalence and acceptance by physicians. Eur. J. Hosp. Pharm. 2018;25:e35–e39. doi: 10.1136/ejhpharm-2017-001251. PubMed DOI PMC

Quek HW, et al. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation. Arch. Gerontol. Geriatr. 2023;107:104910. doi: 10.1016/j.archger.2022.104910. PubMed DOI

Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: Expert review. Gastroenterology. 2022;162:1334–1342. doi: 10.1053/j.gastro.2021.12.247. PubMed DOI

Helgadottir H, Bjornsson ES. Problems associated with deprescribing of proton pump inhibitors. Int. J. Mol. Sci. 2019;20:5469. doi: 10.3390/ijms20215469. PubMed DOI PMC

Dawson KG, Mok V, Wong JGM, Bhalla A. Deprescribing initiative of NSAIDs (DIN): Pharmacist-ledinterventions for pain management in a federal correctionalsetting. Can. Pharm. J. CPJ. 2023;156:85. doi: 10.1177/17151635221149712. PubMed DOI PMC

Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: The D-PRESCRIBE randomized clinical trial. JAMA. 2018;320:1889–1898. doi: 10.1001/jama.2018.16131. PubMed DOI PMC

Glare P, Ashton-James C, Han E, Nicholas M. Deprescribing long-term opioid therapy in patients with chronic pain. Intern. Med. J. 2020;50:1185–1191. doi: 10.1111/imj.15023. PubMed DOI

Langford AV, et al. Patient-targeted interventions for opioid deprescribing: An overview of systematic reviews. Basic Clin. Pharmacol. Toxicol. 2023 doi: 10.1111/BCPT.13844. PubMed DOI PMC

Soni A, Thiyagarajan A, Reeve J. Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: Systematic review and meta-analysis. Addiction. 2023;118:7–16. doi: 10.1111/add.15997. PubMed DOI

Evrard P, Pétein C, Beuscart JB, Spinewine A. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: A systematic review of qualitative and quantitative studies using the theoretical domains framework. Implement. Sci. 2022;17:1–27. doi: 10.1186/s13012-022-01206-7. PubMed DOI PMC

Rochon PA, et al. Polypharmacy, inappropriate prescribing, and deprescribing in older people: Through a sex and gender lens. Lancet Heal. Longev. 2021;2:e290–e300. doi: 10.1016/S2666-7568(21)00054-4. PubMed DOI

Vordenberg SE, et al. Reasons why older adults in three countries agreed with a deprescribing recommendation in a hypothetical vignette. Basic Clin. Pharmacol. Toxicol. 2023 doi: 10.1111/BCPT.13857. PubMed DOI

Barghouth MH, et al. Polypharmacy and the change of self-rated health in community-dwelling older adults. Int. J. Environ. Res. Public Health. 2023;20:4159. doi: 10.3390/ijerph20054159. PubMed DOI PMC

Wuorela M, et al. Self-rated health and objective health status as predictors of all-cause mortality among older people: A prospective study with a 5-, 10-, and 27-year follow-up. BMC Geriatr. 2020;20:1–7. doi: 10.1186/s12877-020-01516-9. PubMed DOI PMC

Lundby C, Pottegård A. Considerations regarding choice of primary outcome in clinical trials in deprescribing. Br. J. Clin. Pharmacol. 2022;88:3032–3034. doi: 10.1111/bcp.14990. PubMed DOI

Bayliss EA, et al. Recommendations for outcome measurement for deprescribing intervention studies. J. Am. Geriatr. Soc. 2022;70:2487–2497. doi: 10.1111/jgs.17894. PubMed DOI PMC

Olesen AE, Væver TJ, Simonsen M, Simonsen PG, Høj K. Deprescribing in primary care without deterioration of health-related outcomes: A real-life, quality improvement project. Basic Clin. Pharmacol. Toxicol. 2023 doi: 10.1111/BCPT.13925. PubMed DOI

Ibrahim K, et al. A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr. 2021;21:1–16. doi: 10.1186/s12877-021-02208-8. PubMed DOI PMC

Garfinkel D. Poly-de-prescribing to treat polypharmacy: Efficacy and safety. Ther. Adv. Drug Saf. 2018;9:25–43. doi: 10.1177/2042098617736192. PubMed DOI PMC

Seewoodharry M, Khunti K, Davies MJ, Gillies C, Seidu S. Attitudes of older adults and their carers towards de-prescribing: A systematic review. Diabet. Med. 2022;39:e14801. doi: 10.1111/dme.14801. PubMed DOI

Weir KR, Ailabouni NJ, Schneider CR, Hilmer SN, Reeve E. Consumer attitudes towards deprescribing: A systematic review and meta-analysis. J. Gerontol. Ser. A. 2022;77:1020–1034. doi: 10.1093/gerona/glab222. PubMed DOI PMC

Komagamine J, Sugawara K, Hagane K. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: A retrospective cross-sectional study. BMC Geriatr. 2018;18:1–6. doi: 10.1186/s12877-018-0788-1. PubMed DOI PMC

Ouellet N, et al. Prescribing and deprescribing in very old age: Perceptions of very old adults, caregivers and health professionals. Age Ageing. 2022;51:afac244. doi: 10.1093/ageing/afac244. PubMed DOI

Mohammed MA, Harrison J, Milosavljevic A, Chan AHY. Attitude towards deprescribing and its association with frailty and complexity of medication regimen: A survey of older inpatients in a district health board in New Zealand. BMC Geriatr. 2023;23:166. doi: 10.1186/s12877-023-03878-2. PubMed DOI PMC

Agency for Medicinal Products and Medical Devices of Croatia, H. Drug Consumption Reports—Drug Consumption | Traffic | Traffic, production and inspection.: HALMED. Report on the consumption of medcines in the Republic of Croatiahttps://www.halmed.hr/Promet-proizvodnja-i-inspekcija/Promet/Potrosnja-lijekova/Izvjesca-o-prometu-lijekova/.

Bužančić I, Ortner Hadžiabdić M. Deprescribing in a multimorbid older adult: A case vignette study among community pharmacists and primary care physicians. Basic Clin. Pharmacol. Toxicol. 2023 doi: 10.1111/BCPT.13899. PubMed DOI

Rhalimi F, Rhalimi M, Rauss A. Pharmacist’s comprehensive geriatric assessment: Introduction and evaluation at elderly patient admission. Drugs Real World Outcomes. 2017;4:43. doi: 10.1007/s40801-016-0098-x. PubMed DOI PMC

Romskaug R, et al. Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: A cluster randomized clinical trial. JAMA Intern. Med. 2020;180:181. doi: 10.1001/jamainternmed.2019.5096. PubMed DOI PMC

Brkic J, et al. Prevalence of potentially inappropriate prescribing in older adults in Central and Eastern Europe: A systematic review and synthesis without meta-analysis. Sci. Rep. 2022;12:16774. doi: 10.1038/s41598-022-19860-8. PubMed DOI PMC

O’Caoimh R, et al. Prevalence of frailty in 62 countries across the world: A systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50:96–104. doi: 10.1093/ageing/afaa219. PubMed DOI

Bredhold BE, et al. Deprescribing opportunities for elderly inpatients in an academic, safety-net health system. Res. Soc. Adm. Pharm. 2021;17:541–544. doi: 10.1016/j.sapharm.2020.04.029. PubMed DOI